| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Priority Reports |
1 Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, Pennsylvania; 2 Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; and 3 Division of Endocrinology, Metabolism and Lipids, Emory University School of Medicine, Atlanta Georgia
Requests for reprints: Elizabeth Moran, Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, PA 19140. Phone: 215-707-7313; Fax: 215-707-6989; E-mail: betty{at}temple.edu.
The activity of mammalian SWI/SNFrelated chromatin remodeling complexes is crucial for differentiation, development, and tumor suppression. Cell cycleregulating activities dependent on the complexes include induction of the p21WAF1/CIP1 kinase inhibitor and repression of E2F-responsive promoters. These responses are linked through effects on pRb phosphorylation, but the direct role of the SWI/SNFrelated complexes in their regulation is not fully understood. Results presented here reveal that the complexes are required for regulation of a distinct pathway of proliferation control involving repression of c-myc expression in differentiating cells. This involves direct promoter targeting of the c-myc gene by the complexes. Induction of p21WAF1/CIP1 is specifically dependent on prior repression of c-myc, but repression of E2F-responsive genes is dissociable from the regulation of c-myc and p21WAF1/CIP1. (Cancer Res 2006; 66(3): 1289-93)
This article has been cited by other articles:
![]() |
R.-K. Kadeppagari, N. Sankar, and B. Thimmapaya Adenovirus Transforming Protein E1A Induces c-Myc in Quiescent Cells by a Novel Mechanism J. Virol., May 15, 2009; 83(10): 4810 - 4822. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Flowers, N. G. Nagl Jr., G. R. Beck Jr., and E. Moran Antagonistic Roles for BRM and BRG1 SWI/SNF Complexes in Differentiation J. Biol. Chem., April 10, 2009; 284(15): 10067 - 10075. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. I. Sims, C. B. Baughman, and G. R. Schnitzler Human SWI/SNF directs sequence-specific chromatin changes on promoter polynucleosomes Nucleic Acids Res., November 1, 2008; 36(19): 6118 - 6131. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. McKenna, C. G. Sansam, Y.-J. Cho, H. Greulich, J. A. Evans, C. S. Thom, L. A. Moreau, J. A. Biegel, S. L. Pomeroy, and C. W. M. Roberts Loss of the Epigenetic Tumor Suppressor SNF5 Leads to Cancer without Genomic Instability Mol. Cell. Biol., October 15, 2008; 28(20): 6223 - 6233. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Verykokakis, C. Papadaki, E. Vorgia, L. Le Gallic, and G. Mavrothalassitis The RAS-dependent ERF Control of Cell Proliferation and Differentiation Is Mediated by c-Myc Repression J. Biol. Chem., October 12, 2007; 282(41): 30285 - 30294. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Gunawardena, S. R. Fox, H. Siddiqui, and E. S. Knudsen SWI/SNF Activity Is Required for the Repression of Deoxyribonucleotide Triphosphate Metabolic Enzymes via the Recruitment of mSin3B J. Biol. Chem., July 13, 2007; 282(28): 20116 - 20123. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |